European Heart Journal

Miscellaneous:

ESC News and Appointments
Eur Heart J 1999 20: I-IV. [PDF] [Request Permissions]  

European Heart Journal Volume 20 (1999) Contents and European Heart Journal Supplements Volume 1 (1999) Contents
Eur Heart J 1999 20: 1-38. [PDF] [Request Permissions]  

Index of authors and Subject index
Eur Heart J 1999 20: 39-75. [PDF] [Request Permissions]  

Hotline editorial:

B Fagerberg

The merit of beta₁-blockade in heart failure
Eur Heart J 1999 20: 1761-1763. [PDF] [References] [Request Permissions]  

J. He and P.K. Whelton

Passive cigarette smoking increases risk of coronary heart disease
Eur Heart J 1999 20: 1764-1765. [PDF] [References] [Request Permissions]  

Editorials:

R. Cappato

What is concealed in concealed accessory pathways?
Eur Heart J 1999 20: 1766-1767. [PDF] [References] [Request Permissions]  

D.C. Shah

The effectiveness and timing of elective pharmacological cardioversion for paroxysmal atrial fibrillation
Eur Heart J 1999 20: 1768-1769. [PDF] [References] [Request Permissions]  

H.-J. Rupprecht and J. Meyer

A plea for provisional stenting
Eur Heart J 1999 20: 1769-1770. [PDF] [References] [Request Permissions]  

B. Meier

Coronary angioplasty after the age of 80 — why not dust where the dust is?
Eur Heart J 1999 20: 1771-1772. [PDF] [References] [Request Permissions]  

Review:

T.F.M. Van Berkel, H. Boersma, J.W. Roos-Hesselink, R.A.M. Erdman, and M.L. Simoons

Impact of smoking cessation and smoking interventions in patients with coronary heart disease
Eur Heart J 1999 20: 1773-1782. [PDF] [References] [Request Permissions]  

Regular articles:

C.J. Knight, N.P. Curzen, P.H. Groves, D.J. Patel, A.H. Goodall, C. Wright, D. Clarke, P.J. Oldershaw, and K.M. Fox

Stent implantation reduces restenosis in patients with suboptimal results following coronary angioplasty
Eur Heart J 1999 20: 1783-1790. [Abstract] [PDF] [References] [Request Permissions]  

J. Kähler, M. Lütke, J. Weckmüller, R. Köster, T. Meinertz, and C.W. Hamm

Coronary angioplasty in octogenarians. Quality of life and costs
Eur Heart J 1999 20: 1791-1798. [Abstract] [PDF] [References] [Request Permissions]  

T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, N. Mabuchi, M. Hayashi, M. Ohnishi, M. Sawaki, M. Fujii, H. Horie, Y. Sugimoto, and M. Kinoshita

Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1
Eur Heart J 1999 20: 1799-1807. [Abstract] [PDF] [References] [Request Permissions]  

H. Kuhn, F.H. Gietzen, M. Schäfers, M. Freick, B. Gockel, C. Strunk-Müller, E. Jachmann, and O. Schober

Changes in the left ventricular outflow tract after transcoronary ablation of septal hypertrophy (TASH) for hypertrophic obstructive cardiomyopathy as assessed by transoesophageal echocardiography and by measuring myocardial glucose utilization and perfusion
Eur Heart J 1999 20: 1808-1817. [Abstract] [PDF] [References] [Request Permissions]  

Y. Miyauchi, Y. Kobayashi, T. Ino, and H. Atarashi

Local slow potential preceding the surface QRS complex detected at the subvalvular mitral annulus in patients with a left-sided concealed accessory pathway. Incidence, electrophysiological characteristics and the possible mechanism, with demonstration of anterograde concealed conduction through the pathway
Eur Heart J 1999 20: 1818-1825. [Abstract] [PDF] [References] [Request Permissions]  

N. Dagres, J.R. Clague, H. Kottkamp, G. Hindricks, G. Breithardt, and M. Borggrefe

Radiofrequency catheter ablation of accessory pathways. Outcome and use of antiarrhythmic drugs during follow-up
Eur Heart J 1999 20: 1826-1832. [Abstract] [PDF] [References] [Request Permissions]  

G. Cotter, A. Blatt, E. Kaluski, E. Metzkor-Cotter, M. Koren, I. Litinski, R. Simantov, Y. Moshkovitz, R. Zaidenstein, E. Peleg, Z. Vered, and A. Golik

Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study
Eur Heart J 1999 20: 1833-1842. [Abstract] [PDF] [References] [Request Permissions]  

Letters to the Editor:

J.-A. Haefliger, J.J. Goy, and G. Waeber

Sporadic cases of dilated cardiomyopathies associated with atrioventricular conduction defects are not linked to mutation within the connexins 40 and 43 genes
Eur Heart J 1999 20: 1843. [PDF] [References] [Request Permissions]  

R. West

Cardiac rehabilitation
Eur Heart J 1999 20: 1844. [PDF] [References] [Request Permissions]  

E.T. Bairaktari, K. Hatzidimou, and M.S. Elisaf

Lipoprotein (a) concentrations in Greek hyperlipidaemic patients: relationship to serum lipid parameters
Eur Heart J 1999 20: 1844. [PDF] [References] [Request Permissions]  

P.E. Dilaveris, D.J. Richter, and J.E. Gialafos

Inadequate blood pressure control in l‘low risk’ Mediterranean population
Eur Heart J 1999 20: 1845. [PDF] [References] [Request Permissions]  

Errata:

AT₁-receptor blockers in hypertension and heart failure: clinical experience and future directions
Eur Heart J 1999 20: 1846. [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.